SG Americas Securities
TYRA icon

SG Americas Securities’s Tyra Biosciences TYRA Stock Holding History

SG Americas Securities’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$940K Buy
29,444
+22,229
+308% +$735K ﹤0.01% 1916
2026
Q1 		$276K Buy
+7,215
New +$234K ﹤0.01% 2499
2025
Q4 		– Sell
-9,542
Closed -$133K – 3777
2025
Q3 		$133K Buy
+9,542
New +$109K ﹤0.01% 2964
2025
Q2 		– Sell
-15,120
Closed -$141K – 3610
2025
Q1 		$141K Buy
15,120
+5,449
+56% +$70.5K ﹤0.01% 2796
2024
Q4 		$134K Sell
9,671
-3,540
-27% -$64.2K ﹤0.01% 2507
2024
Q3 		$311K Buy
+13,211
New +$277K ﹤0.01% 2121

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
APMC
Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

SG Americas Securities's TYRA Position: Q2 2026 in Review

SG Americas Securities increased its Tyra Biosciences (TYRA) stake by 308% in Q2 2026, buying an estimated $735K and bringing the position to 29,444 shares worth $940K. The position accounts for ﹤0.01% of the portfolio, ranked #1916.

SG Americas Securities first reported a position in TYRA in Q3 2024 and has held it in 6 quarters since. 168 funds tracked by Wall St. Rank hold TYRA as of Q2 2026.

  • SG Americas Securities held 29,444 shares of Tyra Biosciences worth $940K as of Q2 2026.
  • SG Americas Securities bought 22,229 Tyra Biosciences shares in Q2 2026, an estimated $735K.
  • Tyra Biosciences made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #1916 holding.
  • SG Americas Securities first reported a position in Tyra Biosciences in Q3 2024 and has held it in 6 quarters since.
  • 168 funds tracked by Wall St. Rank held Tyra Biosciences as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.